MARKET

XCUR

XCUR

Exicure Inc
NASDAQ
2.000
-0.200
-9.09%
Opening 11:54 06/30 EDT
OPEN
2.130
PREV CLOSE
2.200
HIGH
2.500
LOW
1.770
VOLUME
81.70K
TURNOVER
--
52 WEEK HIGH
9.50
52 WEEK LOW
1.710
MARKET CAP
12.75M
P/E (TTM)
-1.2972
1D
5D
1M
3M
1Y
5Y
1D
Exicure names Jin Young Go, Eui Seok Han to board after Ham resignation
PUBT · 3h ago
EXICURE ANNOUNCES BOARD AND COMMITTEE CHANGES
Reuters · 3h ago
Press Release: Exicure Announces Board and Committee Changes
Dow Jones · 3h ago
Exicure Announces Board and Committee Changes
Barchart · 8h ago
Weekly Report: what happened at XCUR last week (0622-0626)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 06/22 21:05
Weekly Report: what happened at XCUR last week (0615-0619)?
Weekly Report · 06/22 09:00
More
About XCUR
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.

Webull offers Exicure Inc stock information, including NASDAQ: XCUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XCUR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XCUR stock methods without spending real money on the virtual paper trading platform.